I3C is released when you chew cruciferous vegetables (broccoli, cauliflower, Brussels sprouts). In the stomach, it converts to DIM (3,3'-diindolylmethane) and other condensation products. Our research shows I3C/DIM modulates estrogen metabolism — shifting the ratio from 16α-hydroxyestrone (growth-promoting, cancer-associated) to 2-hydroxyestrone (protective). This estrogen metabolism shift has moderate evidence for cervical dysplasia (HPV-related), breast cancer risk reduction, and estrogen dominance symptoms. We already have a DIM file — I3C is the precursor that converts to DIM in the stomach.
In the acidic environment of the stomach, I3C undergoes acid-catalyzed condensation to form DIM (~10-20% of I3C converts), ICZ (indolo[3,2-b]carbazole — a potent AhR agonist), and other condensation products. DIM modulates estrogen metabolism by: (1) inducing CYP1A1/1A2 (Phase I enzymes that produce protective 2-OHE1) and suppressing CYP1B1 (which produces genotoxic 4-OHE1); (2) acting as an androgen receptor antagonist at high concentrations; (3) inhibiting NF-κB. The concern: ICZ is a potent aryl hydrocarbon receptor (AhR) agonist — the same receptor activated by dioxin — raising theoretical long-term safety questions that DIM supplementation avoids.
Reviewed by the Scan Dose Research Team and Clinical Advisory Board | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.